Wednesday, November 12, 2008
statines
JUPITER trial: Rosuvastatin cuts CV events in ‘healthy’ people with low LDL, raised CRP
The lipid-lowering drug rosuvastatin nearly halves the risk of major cardiovascular events in apparently healthy people who have normal lipid levels but raised levels of high-sensitivity C-reactive protein, the JUPITER study has found.
# posted by roodbont @ 12:41 AM 
